IDEC Pharmaceuticals Corporation - IDPH- Quotes & Financials

Home » Directory » Pharmaceuticals & Biotechnology » Critical Therapies » IDEC Pharmaceuticals Corporation » Quote & Financials

  • Detailed Quote
  • Stock Chart
  • SEC Filings
  • Balance Sheets
  • Income Statements
  • Cash Flow Statements
  • Earnings Estimates
  • Recommendations

  • Company Financials
    Press Release: Schaeffer's Midday Options Update Features THC ...
    CINCINNATI -- CINCINNATI, June 23 /PRNewswire/ -- Today's Schaeffer's Midday Options Update features Tenet Healthcare , Biogen , IDEC Pharmaceuticals , eBay ...
    http://www.highbeam.com/doc/1G1-104015334.html
    IDEC (NASDAQ: IDPH) has halted clinical trials of its therapeutic ...
    Jun 11, 2002 ... Recent companies profiled include Vertex, EntreMed, Élan, IDEC Pharmaceuticals, Myriad Genetics, and Abgenix. Recent sector reports include ...
    http://www.bioportfolio.com/news/btech_061102_1.htm
    FDA approved IDEC's (NASDAQ: IDPH) Zevalin (ibritumomab tiuxetan)
    Feb 20, 2002 ... Recent companies profiled include Vertex, EntreMed, Élan, IDEC Pharmaceuticals, Myriad Genetics, and Abgenix. Recent sector reports include ...
    http://www.bioportfolio.com/news/btech_022002_2.htm
    IDPH Stock Quote - stock news and information on Boston.com
    IDEC & Biogen investor luncheon presentation. Archive for IDPH. 04/15/03, Q1 2003 Earnings · Archive for IDPH. Powered By: FinancialContent Services, Inc. ...
    http://finance.boston.com/boston?Page=QUOTE&Ticker=IDPH
    Related Business Topics
    Overview  |  Profile  |  News  |  Quote & Financials